Twitter
Google plus
Facebook
Vimeo
Pinterest

Fluid Edge Themes

Title Image

Invitra CBNK™

Umbilical Cord Blood-Derived Natural Killer Cells

Umbilical Cord Blood-Derived Natural Killer Cells

Invitra CBNK™ are minimally manipulated CD56+ natural killer cells derived from umbilical cord blood. Invitra CBNK™ is manufactured using a proprietary isolation and purification technologies.

Natural killer (NK) cells are a type of lymphocyte that has the ability to kill infected or cancerous cells. NK cells are characterized by the presence of CD56 cell surface marker. Umbilical cord blood is an ideal source for NK cells because it occupies a higher percentage of NK cells compared to peripheral blood. NK cells have the ability to kill a wide range of cancers and are a promising tool for both autologous and allogeneic applications.

Dedication to Excellence

Invitrx Therapeutics, headquartered in Orange County California is a global research-based biotechnology company with over 15 years of product development industry experience. Established in 2003, Invitrx Therapeutics has been a leading pioneer in Regenerative Stem Cell Therapies.

Quality Assurance

Invitra CBNK™ is processed from donated umbilical cords from full-term deliveries. All donors are pre-screened and undergo comprehensive testing that includes:

  • Behavioral risk assessment
  • Physical assessment
  • Donor medical history
  • Communicable disease testing
Infectious disease testing is performed at a certified laboratory in accordance with the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and 42 CFR part 493.

Let’s Connect

We look forward to hearing from you! Please also feel free to contact us directly for assistance in finding physicians utilizing our innovative Invitra products.